TGFB1 and cancer: For the six immune subtypes (C1-wound healing, C2-IFN-γ dominant, C3-inflammatory, C4 -lymphocyte depleted, C5-immunologically quiet and C6-TGF-b dominant) of cancers, a significant connection with MYB expression was found in 18 types of cancer including BLCA, BRCA, CESC, CHOL, COAD, HNSC, KIRC, KIRP, LGG, LIHC, LUAD, OV, SARC, STAD, TGCT, THCA, UCEC and UCS (Figure 6).